| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hong Kong | 45 | 2021 | 3361 | 1.73 | Why? |
| Epidemics | 8 | 2021 | 6407 | 0.77 | Why? |
| Epidemiologic Studies | 2 | 2020 | 554 | 0.71 | Why? |
| Child Development | 5 | 2017 | 352 | 0.69 | Why? |
| Medical Record Linkage | 1 | 2017 | 58 | 0.66 | Why? |
| Crowdsourcing | 1 | 2020 | 258 | 0.62 | Why? |
| Body Mass Index | 10 | 2019 | 4306 | 0.61 | Why? |
| Medical Records Systems, Computerized | 1 | 2017 | 159 | 0.58 | Why? |
| Severe Acute Respiratory Syndrome | 18 | 2015 | 12361 | 0.55 | Why? |
| Models, Statistical | 5 | 2020 | 5312 | 0.55 | Why? |
| Video Games | 1 | 2018 | 270 | 0.54 | Why? |
| Polymorphism, Single Nucleotide | 6 | 2020 | 3607 | 0.52 | Why? |
| Birth Weight | 3 | 2017 | 250 | 0.51 | Why? |
| Puberty | 3 | 2017 | 53 | 0.49 | Why? |
| Forecasting | 4 | 2021 | 4492 | 0.48 | Why? |
| Influenza B virus | 1 | 2018 | 815 | 0.48 | Why? |
| Basic Reproduction Number | 2 | 2021 | 2676 | 0.47 | Why? |
| Health Care Reform | 1 | 2018 | 409 | 0.47 | Why? |
| Immunity | 2 | 2020 | 2651 | 0.46 | Why? |
| Disease Outbreaks | 13 | 2021 | 27595 | 0.46 | Why? |
| SARS Virus | 13 | 2010 | 13021 | 0.46 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.44 | Why? |
| Health Planning | 1 | 2018 | 607 | 0.44 | Why? |
| General Practitioners | 1 | 2018 | 568 | 0.43 | Why? |
| Influenza, Human | 7 | 2020 | 10779 | 0.40 | Why? |
| Virtual Reality | 1 | 2018 | 640 | 0.40 | Why? |
| Adiposity | 5 | 2019 | 329 | 0.40 | Why? |
| Informed Consent | 1 | 2017 | 890 | 0.39 | Why? |
| Communicable Diseases, Emerging | 2 | 2021 | 2523 | 0.39 | Why? |
| Virus Shedding | 4 | 2020 | 5834 | 0.38 | Why? |
| Disease Transmission, Infectious | 4 | 2020 | 9044 | 0.38 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.36 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.36 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.35 | Why? |
| Adolescent Development | 2 | 2017 | 55 | 0.34 | Why? |
| Coronavirus Infections | 20 | 2020 | 253789 | 0.34 | Why? |
| Breast Feeding | 4 | 2019 | 1585 | 0.33 | Why? |
| Health Care Costs | 1 | 2015 | 1007 | 0.33 | Why? |
| Markov Chains | 3 | 2020 | 502 | 0.32 | Why? |
| Infectious Disease Incubation Period | 3 | 2020 | 1033 | 0.32 | Why? |
| Research | 1 | 2020 | 2115 | 0.32 | Why? |
| Models, Theoretical | 4 | 2021 | 6659 | 0.32 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.32 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.32 | Why? |
| Travel | 3 | 2021 | 7220 | 0.31 | Why? |
| Blood Pressure | 4 | 2019 | 2198 | 0.31 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2020 | 2984 | 0.31 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.31 | Why? |
| Problem Behavior | 2 | 2018 | 176 | 0.30 | Why? |
| Cell Adhesion Molecules | 4 | 2010 | 472 | 0.30 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2019 | 6166 | 0.30 | Why? |
| Pneumonia, Viral | 17 | 2020 | 243684 | 0.28 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.28 | Why? |
| Humans | 93 | 2021 | 930598 | 0.27 | Why? |
| Pandemics | 23 | 2021 | 389249 | 0.27 | Why? |
| China | 20 | 2020 | 50654 | 0.26 | Why? |
| Early Detection of Cancer | 1 | 2015 | 1956 | 0.26 | Why? |
| Age Factors | 6 | 2020 | 21039 | 0.25 | Why? |
| Pediatric Obesity | 2 | 2018 | 492 | 0.24 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.24 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.24 | Why? |
| Lectins, C-Type | 3 | 2010 | 405 | 0.24 | Why? |
| Respiratory Tract Infections | 2 | 2020 | 6817 | 0.23 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.22 | Why? |
| Influenza A Virus, H7N9 Subtype | 2 | 2017 | 415 | 0.22 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.22 | Why? |
| Receptors, Cell Surface | 3 | 2010 | 586 | 0.22 | Why? |
| Health Systems Agencies | 1 | 2020 | 12 | 0.21 | Why? |
| Myocardial Ischemia | 2 | 2018 | 781 | 0.21 | Why? |
| Body Height | 2 | 2019 | 100 | 0.21 | Why? |
| Primary Health Care | 2 | 2018 | 4839 | 0.21 | Why? |
| Mendelian Randomization Analysis | 2 | 2020 | 317 | 0.21 | Why? |
| Healthcare Disparities | 1 | 2018 | 3893 | 0.21 | Why? |
| Child | 28 | 2020 | 70012 | 0.21 | Why? |
| Computer Systems | 1 | 2001 | 255 | 0.20 | Why? |
| Growth | 1 | 2019 | 19 | 0.20 | Why? |
| Adolescent | 33 | 2020 | 86841 | 0.20 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.19 | Why? |
| Practice Management, Medical | 1 | 2001 | 118 | 0.19 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2020 | 368 | 0.19 | Why? |
| Monte Carlo Method | 2 | 2020 | 577 | 0.19 | Why? |
| Calibration | 1 | 2019 | 307 | 0.19 | Why? |
| Nitrogen Dioxide | 2 | 2019 | 488 | 0.18 | Why? |
| Health Information Systems | 1 | 2020 | 130 | 0.18 | Why? |
| Economics | 1 | 2020 | 196 | 0.18 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.18 | Why? |
| Minichromosome Maintenance Complex Component 6 | 1 | 2017 | 2 | 0.18 | Why? |
| Promoter Regions, Genetic | 3 | 2010 | 823 | 0.18 | Why? |
| Eutheria | 1 | 2020 | 313 | 0.17 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.17 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.17 | Why? |
| Breast Neoplasms | 1 | 2015 | 3633 | 0.17 | Why? |
| Prenatal Exposure Delayed Effects | 2 | 2019 | 319 | 0.17 | Why? |
| Environmental Exposure | 2 | 2019 | 1558 | 0.17 | Why? |
| Transients and Migrants | 3 | 2018 | 1468 | 0.16 | Why? |
| Intergenerational Relations | 1 | 2017 | 102 | 0.16 | Why? |
| Cross Protection | 1 | 2019 | 373 | 0.16 | Why? |
| Self Concept | 2 | 2018 | 490 | 0.16 | Why? |
| Infant | 14 | 2020 | 30274 | 0.16 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2017 | 115 | 0.16 | Why? |
| Antineoplastic Protocols | 1 | 2015 | 25 | 0.16 | Why? |
| Genome-Wide Association Study | 2 | 2020 | 1648 | 0.15 | Why? |
| Air Pollutants | 3 | 2019 | 3110 | 0.15 | Why? |
| Female | 46 | 2020 | 380317 | 0.15 | Why? |
| Cohort Studies | 13 | 2019 | 36005 | 0.15 | Why? |
| Milk | 1 | 2017 | 158 | 0.15 | Why? |
| Population Surveillance | 3 | 2021 | 4967 | 0.15 | Why? |
| Male | 44 | 2020 | 367725 | 0.15 | Why? |
| Adolescent Behavior | 2 | 2018 | 400 | 0.15 | Why? |
| Holidays | 1 | 2018 | 311 | 0.15 | Why? |
| Models, Economic | 1 | 2018 | 316 | 0.15 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.15 | Why? |
| Child, Preschool | 17 | 2020 | 36283 | 0.15 | Why? |
| Radiotherapy, Adjuvant | 1 | 2015 | 180 | 0.14 | Why? |
| Air Pollution | 3 | 2019 | 3504 | 0.14 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.14 | Why? |
| Disease Notification | 2 | 2017 | 639 | 0.14 | Why? |
| Cholesterol | 1 | 2019 | 660 | 0.14 | Why? |
| History, 21st Century | 2 | 2021 | 1849 | 0.14 | Why? |
| Premature Birth | 2 | 2017 | 2151 | 0.14 | Why? |
| Patient Isolation | 4 | 2020 | 3182 | 0.14 | Why? |
| Communicable Disease Control | 4 | 2020 | 29620 | 0.14 | Why? |
| Incidence | 8 | 2020 | 25622 | 0.14 | Why? |
| Depression, Postpartum | 1 | 2018 | 282 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Evolution, Molecular | 2 | 2020 | 3691 | 0.13 | Why? |
| Enterovirus | 1 | 2017 | 402 | 0.13 | Why? |
| Intersectoral Collaboration | 1 | 2021 | 1065 | 0.13 | Why? |
| Adult | 27 | 2020 | 244371 | 0.13 | Why? |
| Diabetes Mellitus | 2 | 2017 | 8207 | 0.13 | Why? |
| Hospitalization | 9 | 2020 | 54280 | 0.13 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.12 | Why? |
| Papillomavirus Vaccines | 1 | 2018 | 405 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Quality-Adjusted Life Years | 1 | 2015 | 511 | 0.12 | Why? |
| Diabetes, Gestational | 1 | 2018 | 426 | 0.12 | Why? |
| Chemotherapy, Adjuvant | 1 | 2015 | 606 | 0.12 | Why? |
| Singapore | 2 | 2019 | 3641 | 0.12 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.12 | Why? |
| Child Welfare | 1 | 2017 | 405 | 0.12 | Why? |
| Young Adult | 13 | 2020 | 93724 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2020 | 2483 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Testis | 1 | 2017 | 566 | 0.11 | Why? |
| Mammography | 1 | 2015 | 410 | 0.11 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.11 | Why? |
| Seasons | 3 | 2018 | 4071 | 0.11 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.11 | Why? |
| Infant, Newborn | 10 | 2019 | 23105 | 0.11 | Why? |
| Risk Factors | 11 | 2020 | 71621 | 0.11 | Why? |
| Immunogenetic Phenomena | 1 | 2010 | 61 | 0.10 | Why? |
| Overweight | 1 | 2017 | 916 | 0.10 | Why? |
| Milk, Human | 1 | 2019 | 956 | 0.10 | Why? |
| Asymptomatic Diseases | 2 | 2020 | 3444 | 0.10 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.10 | Why? |
| Aged | 17 | 2020 | 215776 | 0.10 | Why? |
| GTP-Binding Proteins | 1 | 2010 | 132 | 0.10 | Why? |
| Masks | 3 | 2021 | 8528 | 0.10 | Why? |
| Influenza in Birds | 1 | 2015 | 528 | 0.10 | Why? |
| Global Health | 5 | 2021 | 13911 | 0.10 | Why? |
| Follow-Up Studies | 7 | 2019 | 17020 | 0.10 | Why? |
| Cities | 2 | 2018 | 4937 | 0.10 | Why? |
| Chickens | 1 | 2015 | 1010 | 0.10 | Why? |
| Middle Aged | 20 | 2020 | 270681 | 0.10 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.09 | Why? |
| Genetic Predisposition to Disease | 5 | 2017 | 4027 | 0.09 | Why? |
| Antibodies, Viral | 4 | 2019 | 51949 | 0.09 | Why? |
| Sulfur Dioxide | 2 | 2019 | 99 | 0.09 | Why? |
| Influenza A virus | 2 | 2017 | 2234 | 0.09 | Why? |
| Delivery, Obstetric | 1 | 2017 | 1292 | 0.09 | Why? |
| Particulate Matter | 2 | 2017 | 3249 | 0.09 | Why? |
| Immunoglobulin G | 3 | 2009 | 21571 | 0.09 | Why? |
| Urban Population | 1 | 2018 | 2000 | 0.09 | Why? |
| Sex Factors | 4 | 2018 | 11014 | 0.09 | Why? |
| Socioeconomic Factors | 6 | 2018 | 8495 | 0.09 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.09 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.08 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.08 | Why? |
| Logistic Models | 4 | 2018 | 9089 | 0.08 | Why? |
| Body Composition | 1 | 2011 | 414 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.08 | Why? |
| Smartphone | 1 | 2018 | 1840 | 0.08 | Why? |
| Immunologic Memory | 1 | 2019 | 3362 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Risk | 3 | 2020 | 5288 | 0.08 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.08 | Why? |
| Health Policy | 3 | 2021 | 6242 | 0.08 | Why? |
| Self Disclosure | 1 | 2005 | 12 | 0.08 | Why? |
| L-Lactate Dehydrogenase | 3 | 2010 | 1995 | 0.08 | Why? |
| Antigens, CD | 2 | 2010 | 984 | 0.07 | Why? |
| Depression | 3 | 2018 | 14116 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Seroepidemiologic Studies | 4 | 2009 | 10017 | 0.07 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Age Distribution | 5 | 2017 | 3567 | 0.07 | Why? |
| Mental Recall | 1 | 2005 | 77 | 0.07 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.07 | Why? |
| Gene Frequency | 4 | 2010 | 1210 | 0.07 | Why? |
| Interferon-beta | 1 | 2010 | 979 | 0.07 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.07 | Why? |
| Muscle, Skeletal | 1 | 2011 | 915 | 0.07 | Why? |
| HLA Antigens | 1 | 2010 | 830 | 0.07 | Why? |
| Odds Ratio | 3 | 2011 | 5861 | 0.06 | Why? |
| Contact Tracing | 4 | 2020 | 8448 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Analysis of Variance | 2 | 2008 | 950 | 0.06 | Why? |
| Schools | 1 | 2018 | 4187 | 0.06 | Why? |
| Social Class | 1 | 2011 | 1360 | 0.06 | Why? |
| Lipids | 2 | 2019 | 1079 | 0.06 | Why? |
| Immunotherapy | 1 | 2015 | 2421 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Models, Biological | 1 | 2019 | 4907 | 0.06 | Why? |
| Asthma | 2 | 2019 | 4383 | 0.06 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.06 | Why? |
| Gestational Age | 2 | 2017 | 1488 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.05 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.05 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.05 | Why? |
| Pregnancy | 6 | 2019 | 23879 | 0.05 | Why? |
| Polymorphism, Genetic | 1 | 2008 | 1074 | 0.05 | Why? |
| Nitric Oxide | 2 | 2019 | 769 | 0.05 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.05 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.05 | Why? |
| Far East | 1 | 2020 | 125 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.05 | Why? |
| Data Collection | 1 | 2009 | 1769 | 0.05 | Why? |
| Sex Distribution | 3 | 2017 | 2083 | 0.05 | Why? |
| Sexual Maturation | 1 | 2019 | 18 | 0.05 | Why? |
| Geography | 1 | 2006 | 1801 | 0.05 | Why? |
| Genetic Markers | 1 | 2021 | 318 | 0.05 | Why? |
| Epidemiologic Methods | 1 | 2003 | 392 | 0.05 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.05 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.05 | Why? |
| Databases, Factual | 2 | 2015 | 6248 | 0.05 | Why? |
| Health Care Surveys | 2 | 2007 | 2942 | 0.05 | Why? |
| Genotype | 4 | 2015 | 4697 | 0.05 | Why? |
| Quarantine | 4 | 2021 | 18418 | 0.05 | Why? |
| Probability | 3 | 2008 | 923 | 0.05 | Why? |
| Lebanon | 1 | 2021 | 557 | 0.05 | Why? |
| Interinstitutional Relations | 1 | 2020 | 170 | 0.05 | Why? |
| Lipoproteins, LDL | 1 | 2019 | 115 | 0.05 | Why? |
| Hemagglutinins | 1 | 2019 | 143 | 0.04 | Why? |
| Longitudinal Studies | 3 | 2019 | 9893 | 0.04 | Why? |
| Healthcare Financing | 1 | 2020 | 129 | 0.04 | Why? |
| Health Status Disparities | 1 | 2016 | 4072 | 0.04 | Why? |
| Sex Ratio | 1 | 2018 | 69 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2001 | 961 | 0.04 | Why? |
| Hyperinsulinism | 1 | 2017 | 27 | 0.04 | Why? |
| Infant Nutritional Physiological Phenomena | 1 | 2018 | 75 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2019 | 154 | 0.04 | Why? |
| Vital Capacity | 1 | 2019 | 399 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.04 | Why? |
| Maternal Age | 1 | 2017 | 244 | 0.04 | Why? |
| Exhalation | 1 | 2020 | 441 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Triglycerides | 1 | 2019 | 478 | 0.04 | Why? |
| Cluster Analysis | 2 | 2020 | 3001 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2019 | 632 | 0.04 | Why? |
| Confidence Intervals | 2 | 2008 | 744 | 0.04 | Why? |
| Health Expenditures | 2 | 2017 | 904 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Malaysia | 1 | 2020 | 1116 | 0.04 | Why? |
| Enterovirus A, Human | 1 | 2017 | 180 | 0.04 | Why? |
| Maternal Exposure | 1 | 2017 | 173 | 0.04 | Why? |
| Food Preferences | 1 | 2017 | 128 | 0.04 | Why? |
| Cholesterol, LDL | 1 | 2019 | 499 | 0.04 | Why? |
| Case-Control Studies | 5 | 2017 | 17671 | 0.04 | Why? |
| Stochastic Processes | 2 | 2009 | 369 | 0.04 | Why? |
| Public Health Practice | 1 | 2003 | 945 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.03 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 572 | 0.03 | Why? |
| Parent-Child Relations | 1 | 2018 | 384 | 0.03 | Why? |
| Community Participation | 1 | 2021 | 605 | 0.03 | Why? |
| Bone Density | 1 | 2017 | 335 | 0.03 | Why? |
| Policy Making | 1 | 2021 | 829 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Zoonoses | 2 | 2020 | 3034 | 0.03 | Why? |
| New Zealand | 1 | 2020 | 2073 | 0.03 | Why? |
| Pharynx | 1 | 2021 | 1544 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 8843 | 0.03 | Why? |
| Cross Infection | 3 | 2015 | 8675 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Reassortant Viruses | 1 | 2015 | 287 | 0.03 | Why? |
| Pakistan | 1 | 2021 | 2302 | 0.03 | Why? |
| Body Weight | 1 | 2019 | 1074 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Antibody Formation | 1 | 2006 | 4038 | 0.03 | Why? |
| Blood Donors | 1 | 2006 | 2956 | 0.03 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.03 | Why? |
| Family Health | 1 | 2017 | 731 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Israel | 1 | 2020 | 2751 | 0.03 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.03 | Why? |
| Transcription Factor AP-2 | 1 | 2010 | 9 | 0.03 | Why? |
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 56 | 0.03 | Why? |
| Commerce | 1 | 2020 | 1109 | 0.03 | Why? |
| Myxovirus Resistance Proteins | 1 | 2010 | 77 | 0.03 | Why? |
| Sp1 Transcription Factor | 1 | 2010 | 33 | 0.03 | Why? |
| Disease Reservoirs | 1 | 2020 | 1672 | 0.03 | Why? |
| Public Opinion | 1 | 2021 | 1165 | 0.03 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.02 | Why? |
| Lung | 1 | 2019 | 31049 | 0.02 | Why? |
| Ecosystem | 1 | 2015 | 776 | 0.02 | Why? |
| DNA Probes | 1 | 2010 | 178 | 0.02 | Why? |
| Heterozygote | 1 | 2010 | 249 | 0.02 | Why? |
| Homozygote | 1 | 2010 | 230 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 13720 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2015 | 3198 | 0.02 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.02 | Why? |
| Tandem Repeat Sequences | 1 | 2008 | 78 | 0.02 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2020 | 6049 | 0.02 | Why? |
| Cost Sharing | 1 | 2007 | 39 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.02 | Why? |
| Animals | 4 | 2020 | 78931 | 0.02 | Why? |
| Nuclear Proteins | 1 | 2010 | 321 | 0.02 | Why? |
| Transfection | 1 | 2010 | 864 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Financing, Personal | 1 | 2007 | 113 | 0.02 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.02 | Why? |
| Perception | 1 | 2018 | 2827 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Politics | 1 | 2020 | 1824 | 0.02 | Why? |
| HeLa Cells | 1 | 2010 | 1303 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2015 | 4260 | 0.02 | Why? |
| Bayes Theorem | 1 | 2015 | 3237 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Episode of Care | 1 | 2005 | 27 | 0.02 | Why? |
| Reference Values | 1 | 2008 | 795 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Information Dissemination | 1 | 2021 | 2986 | 0.02 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.02 | Why? |
| Databases as Topic | 1 | 2005 | 103 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| DNA | 1 | 2010 | 778 | 0.02 | Why? |
| Parents | 1 | 2018 | 2758 | 0.02 | Why? |
| Endemic Diseases | 1 | 2008 | 480 | 0.02 | Why? |
| Japan | 1 | 2017 | 6653 | 0.02 | Why? |
| Social Support | 1 | 2018 | 3183 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Mathematics | 1 | 2003 | 65 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.02 | Why? |
| Alleles | 1 | 2008 | 1557 | 0.01 | Why? |
| Republic of Korea | 1 | 2015 | 5858 | 0.01 | Why? |
| Interferon-alpha | 1 | 2010 | 1442 | 0.01 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2009 | 1316 | 0.01 | Why? |
| Antigens, Viral | 1 | 2019 | 6298 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Survival Rate | 2 | 2008 | 9206 | 0.01 | Why? |
| Likelihood Functions | 1 | 2003 | 719 | 0.01 | Why? |
| Asia | 1 | 2007 | 2399 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Health Personnel | 2 | 2009 | 29646 | 0.01 | Why? |
| Bias | 1 | 2005 | 1109 | 0.01 | Why? |
| Leukocyte Count | 1 | 2007 | 3178 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2001 | 43792 | 0.01 | Why? |
| Protein Binding | 1 | 2010 | 11430 | 0.01 | Why? |
| Communicable Diseases | 1 | 2008 | 2148 | 0.01 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Algorithms | 1 | 2009 | 7346 | 0.01 | Why? |
| Immunity, Innate | 1 | 2010 | 6570 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 9706 | 0.00 | Why? |
| Cytokines | 1 | 2008 | 15010 | 0.00 | Why? |
| Registries | 1 | 2005 | 12327 | 0.00 | Why? |
| Disease Progression | 1 | 2003 | 13580 | 0.00 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.00 | Why? |